Association between three common genetic polymorphisms of xeroderma pigmentosum complementation group C (XPC) and susceptibility to opium dependency.

Authors: Qasemian-Talgard, Arghavan¹ (AUTHOR), Saadat, Mostafa¹ (AUTHOR) saadat@shirazu.ac.ir

Source: Egyptian Journal of Medical Human Genetics. 12/9/2024, Vol. 25 Issue 1, p1-6. 6p.

Subject Terms: *XERODERMA pigmentosum, *HAPLOTYPES, *ODDS ratio, *CONFIDENCE intervals, *GENOTYPES

Tendances de la maladie de Kaposi en milieu hospitalier de 1990 à 2020 à Lomé (Togo).

Alternate Title: Trends in Kaposi's disease in the hospital setting from 1990 to 2020 in Lomé (Togo).

Authors: Akakpo, Abla Sefako¹ sefasyl@yahoo.fr, Kamno, Kelly Tcheumagam¹, Téclessou, Julienne Noude², Kassang, Panawé¹, Gnossike, Piham³, Mouhari-Touré, Abas³, Kombaté, Koussaké², Tchangai-Walla, Kissem¹, Saka, Bayaki¹, Pitché, Palokinam¹

Source: Our Dermatology Online / Nasza Dermatologia Online. 2024 Supplement, Vol. 15, p37-42. 6p.

Subject Terms: *XERODERMA pigmentosum, *ANTIRETROVIRAL agents, *DERMATOLOGY, *MORTALITY, *DIAGNOSIS

Cutaneous mastocytosis in a child with xeroderma pigmentosum: A case report.

Authors: Baklan, E.¹, Duman, N.¹ nilay.duman@ege.edu.tr, Akalın, T.², Karaarslan, I.¹

Source: European Journal of Pediatric Dermatology. 2024, Vol. 34 Issue 2, p112-115. 4p.

Subject Terms: *MAST cell disease, *XERODERMA pigmentosum, *MAST cells, *SKIN biopsy, *RARE diseases, *PHOTOSENSITIVITY

Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients.

Authors: Sagun, Jeffrey P.¹, Khan, Sikandar G.¹, Imoto, Kyoko^1,2, Tamura, Deborah¹, Oh, Kyu-Seon^1,3, DiGiovanna, John J.¹, Kraemer, Kenneth H.¹, kraemerk@nih.gov

Source: PLoS Genetics; 12/2/2024, Vol. 20 Issue 12, p1-27, 27p

Evaluation of the effectiveness and safety of combined oral and topical photoprotection with a standardized extract of Polypodium leucotomos (Fernblock®) in a Moroccan population with xeroderma pigmentosum.

Authors: El Mansouri, M.¹ (AUTHOR), Essaddouki, S.¹ (AUTHOR), Mouradi, M.¹ (AUTHOR), Oukerroum, A.² (AUTHOR), El Fatoiki, F. Z.¹ (AUTHOR), Truchuelo, M. T.³ (AUTHOR) maytetd@yahoo.es, Vitale, M. A.⁴ (AUTHOR), González, S.⁵ (AUTHOR), Chiheb, S.¹ (AUTHOR)

Source: Photodermatology, Photoimmunology & Photomedicine. Nov2023, Vol. 39 Issue 6, p607-612. 6p.

Subject Terms: *XERODERMA pigmentosum, *MOROCCANS, *SUNSHINE, *VITAMIN D, *ORAL health, *SATISFACTION

Geographic Terms: MOROCCO

Acceptability and influence of a complex personalized intervention on changes in photoprotection behaviours among people with xeroderma pigmentosum.

Authors: Walburn, Jessica¹ (AUTHOR) jessica.walburn@kcl.ac.uk, Foster, Lesley² (AUTHOR), Araújo‐Soares, Vera³ (AUTHOR), Sarkany, Robert² (AUTHOR), Weinman, John¹ (AUTHOR), Sainsbury, Kirby⁴ (AUTHOR), Morgan, Myfanwy¹ (AUTHOR)

Source: British Journal of Health Psychology. Nov2023, Vol. 28 Issue 4, p1113-1131. 19p.

Subject Terms: *XERODERMA pigmentosum, *PATIENT experience, *SKIN cancer, *PATIENTS' attitudes, *TEXT messages, *SELF-confidence, *HABIT

Brazilian XP-E siblings carrying a novel DDB2 variant developed early-onset melanoma: a case report.

Authors: de Souza Timoteo, Ana Rafaela¹ (NURSE), Pinheiro de Almeida, Isabel Cristina² (NURSE), Yurchenko, Andrey A³ (AUTHOR), de Miranda Henriques, Sheila Ramos² (NURSE), de Souza Segundo, Paulo⁴ (NURSE), Rajabi, Fatemeh³ (AUTHOR), Nikolaev, Sergey³ (AUTHOR), Petta, Tirzah Braz^1,5 (NURSE) tirzah.petta@usc.edu

Source: BMC Medical Genomics. 8/12/2023, Vol. 16 Issue 1, p1-7. 7p.

Subject Terms: *SKIN cancer, *XERODERMA pigmentosum, *MELANOMA, *SIBLINGS, *MISSENSE mutation, *COVID-19 pandemic

Imiquimod chemoprophylaxis for field cancerization in xeroderma pigmentosum patients—A prospective study.

Authors: Rocha, Lílian Kelly Faria Licarião¹ (AUTHOR) lilianrocha@me.com, Ferreira, Paula² (AUTHOR), Gianotti, Marcelo A.² (AUTHOR), Avancini, João² (AUTHOR), Menck, Carlos F. M.³ (AUTHOR), Castro, Ligia P.³ (AUTHOR), de Oliveira, Zilda Najjar Prado² (AUTHOR), Rivitti, Maria C.² (AUTHOR), Samorano, Luciana P.² (AUTHOR), Pereira, Naiura Vieira⁴ (AUTHOR), Festa Neto, Cyro¹ (AUTHOR)

Source: Australasian Journal of Dermatology. Aug2023, Vol. 64 Issue 3, p435-438. 4p. 2 Color Photographs, 1 Diagram.

Subject Terms: *XERODERMA pigmentosum, *IMIQUIMOD, *CHEMOPREVENTION, *IMMUNOMODULATORS, *SKIN cancer, *LONGITUDINAL method, *SUNBURN

Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde.

Authors: Voufo, Roger Ahouga^1,2 (AUTHOR), Kouotou, Armand Emmanuel³ (AUTHOR), Tatah, Nchinda Jones² (AUTHOR), TeTo, Georges⁴ (AUTHOR), Gueguim, Cédric² (AUTHOR), Ngondé, Chantal Marie Essome¹ (AUTHOR), Njiguet Tepa, Armand Gabin¹ (AUTHOR), Gabin, Arnaud² (AUTHOR), Amazia, Falmata² (AUTHOR), Yembeau, Natacha Lena⁵ (AUTHOR), Kouanfack, Charles⁶ (AUTHOR), Anatole, Pieme Constant² (AUTHOR) apieme@yahoo.fr

Source: Virology Journal. 7/25/2023, Vol. 20 Issue 1, p1-8. 8p.

Subject Terms: *XERODERMA pigmentosum, *HIV, *INTERLEUKIN-6, *OXIDANT status, *HIV status, *OXIDATIVE stress

Geographic Terms: YAOUNDE (Cameroon)

Frequent Occurrence of High‐Risk Basal Cell Carcinoma in Xeroderma Pigmentosum: A Histopathological Insight From an Indian Cohort.

Authors: Imran, Shafaque¹ (AUTHOR), Dagar, Shivangi² (AUTHOR), Ahuja, Rhea¹ (AUTHOR), Swaroop, Devesh Kumar Jag¹ (AUTHOR), Gupta, Somesh¹ (AUTHOR), Arava, Sudheer² (AUTHOR), Verma, Kaushal K.¹ (AUTHOR), Bhari, Neetu¹ (AUTHOR) drntbhari@gmail.com

Source: Journal of Cutaneous Pathology. Nov2024, p1. 8p. 4 Illustrations.

Subject Terms: *BASAL cell carcinoma, *XERODERMA pigmentosum, *PREMATURE aging (Medicine), *SKIN cancer, *SKIN tumors

Th e burden of xeroderma pigmentosum in two families followed at the Department of Dermatology and Venereology of the National Hospital in Niamey, Niger.

Authors: Salissou, Laouali¹ danmata@yahoo.com, Ouédraogo, Muriel Sidnoma², Ango, Aissa¹, Diori, Adam Nouhou³, Hamani, Issaka⁴, Boubacar, Idrissa⁵, Mamadou, Maimouna Oueodraogo¹, Laouali Idi, Mamane Sani¹, Doulla, Moussa¹, Nouhou, Hassan⁶, Korsaga/Somé, Nina², Barro/Traore, Fatou², Pascal, Niamba², Traore, Adama²

Source: Our Dermatology Online / Nasza Dermatologia Online. Apr2023, Vol. 14 Issue 2, p156-160. 5p.

Subject Terms: *XERODERMA pigmentosum, *PUBLIC hospitals, *GENETIC counseling, *SQUAMOUS cell carcinoma, *DERMATOLOGY, *SKIN cancer

Geographic Terms: NIAMEY (Niger), NIGER

The therapeutic dental challenge of xeroderma pigmentosum patients: case report.

Authors: Hanine, Yasmine¹ yasminehanine@uir.ac.ma, Ghoul, Sonia¹, Cherkaoui, Amine²

Source: Pan African Medical Journal. Jan-Apr2023, Vol. 44, p1-6. 6p.

Subject Terms: *XERODERMA pigmentosum, *DENTAL offices, *GENETIC disorders, *ULTRAVIOLET radiation, *DNA, *SKIN cancer, *DENTAL caries

Xeroderma pigmentosum: Twelve cases at the National Hospital of Niamey, Niger.

Authors: Laouali, Salissou¹ danmata@yahoo.com, Adam, Nouhou Diori², Issaka, Hamani³, Maïmouna, Oueodraogo Mamadou¹, Sani, Laouali Idi Mamane¹, Doulla, Moussa¹, Hassan, Nouhou⁴

Source: Our Dermatology Online / Nasza Dermatologia Online. Jan2023, Vol. 14 Issue 1, p56-59. 4p.

Subject Terms: *XERODERMA pigmentosum, *PUBLIC hospitals, *DNA ligases, *ENZYME deficiency, *SOLAR radiation

Geographic Terms: NIAMEY (Niger), NIGER

Evidence for the involvement of keratinocyte‐derived microvesicle particles in the photosensitivity associated with xeroderma pigmentosum type A deficiency.

Authors: Christian, Lea¹ (AUTHOR), Manjrekar, Pranali¹ (AUTHOR), Henkels, Karen M.¹ (AUTHOR), Rapp, Christine M.¹ (AUTHOR), Annamraju, Risha¹ (AUTHOR), Lohade, Rushabh P.¹ (AUTHOR), Singh, Shikshita¹ (AUTHOR), Carpenter, M. Alexandra¹ (AUTHOR), Khan, Saman¹ (AUTHOR), Kemp, Michael G.^1,2 (AUTHOR), Chen, Yanfang¹ (AUTHOR), Sahu, Ravi P.¹ (AUTHOR), Travers, Jeffrey B.^1,2,3 (AUTHOR) jeffrey.travers@wright.edu

Source: Photochemistry & Photobiology. Sep2024, Vol. 100 Issue 5, p1457-1466. 10p.

Subject Terms: *XERODERMA pigmentosum, *KNOCKOUT mice, *PHOTOSENSITIVITY, *ULTRAVIOLET radiation, *SPHINGOMYELINASE

Kaposi disease revealing HIV treatment breach: A report of two cases.

Authors: Attal, Camille¹ (AUTHOR), Demoury, Benjamin¹ (AUTHOR), Reimbold, Pierre² (AUTHOR), Mensah, Aurore³ (AUTHOR), Lescaille, Géraldine¹ (AUTHOR), Rochefort, Juliette¹ (AUTHOR) juliette.rochefort@aphp.fr

Source: Clinical Case Reports. Aug2024, Vol. 12 Issue 8, p1-6. 6p.

Subject Terms: *SEXUALLY transmitted diseases, *XERODERMA pigmentosum, *VIRAL load, *INFECTION, *ORAL surgeons

The XPA Protein—Life under Precise Control.

Authors: Krasikova, Yuliya S.¹ (AUTHOR), Lavrik, Olga I.^1,2 (AUTHOR), Rechkunova, Nadejda I.¹ (AUTHOR) nadyarec@niboch.nsc.ru

Source: Cells (2073-4409). Dec2022, Vol. 11 Issue 23, p3723. 29p.

Subject Terms: *XERODERMA pigmentosum, *DNA repair, *PROTEINS, *PROTEIN structure, *POLYPEPTIDES

Thromboembolic disease in a patient treated with bleomycin for endemic Kaposi's disease at the Bamako Dermatology Hospital in Mali.

Authors: Moussa, Savané^1,2,3 moussasavan@ymail.com, Guindo, Binta¹, Keita, Alimata¹, Diakité, Mamoudou¹, Gassama, Mamadou^1,2, Fofana, Youssouf⁴, Karabinta, Yamoussa^1,2, Dissa, Labassou¹, Mukendi, Nkesu Yannick¹, Dicko, Adama A.^1,2, Cissé, Mohamed^3,5, Faye, Ousmane^1,2

Source: Our Dermatology Online / Nasza Dermatologia Online. Jul2023, Vol. 14 Issue 3, p287-289. 3p.

Subject Terms: *XERODERMA pigmentosum, *BLEOMYCIN, *THROMBOEMBOLISM, *DERMATOLOGY

Geographic Terms: MALI

Evaluation of Photoaging and Sun Protection Behavior in Children With Xeroderma Pigmentosum, Group C: A Prospective Analysis.

Authors: Ahuja, Rhea¹ (AUTHOR), Imran, Shafaque¹ (AUTHOR), Swaroop, Devesh Kumar Jag¹ (AUTHOR), Gupta, Somesh¹ (AUTHOR), Verma, Kaushal K.¹ (AUTHOR), Sharma, Namrata¹ (AUTHOR), Bhari, Neetu¹ (AUTHOR) drntbhari@gmail.com

Source: Pediatric Dermatology. Dec2024, p1. 3p. 1 Illustration.

Subject Terms: *CHILD behavior, *XERODERMA pigmentosum, *CHILD welfare, *DERMOSCOPY

Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma.

Authors: Chikhaoui, Asma^1,2 (AUTHOR), Jones, Meriem³ (AUTHOR), Režen, Tadeja⁴ (AUTHOR), Ben Ahmed, Melika⁵ (AUTHOR), Naouali, Chokri^1,2 (AUTHOR), Komel, Radovan⁴ (AUTHOR), Zghal, Mohamed³ (AUTHOR), Boubaker, Samir^1,2 (AUTHOR), Abdelhak, Sonia^1,2 (AUTHOR), Yacoub-Youssef, Houda^1,2 (AUTHOR) houda.yacoub@pasteur.utm.tn

Source: Scientific Reports. 8/16/2022, Vol. 12 Issue 1, p1-13. 13p.

Subject Terms: *XERODERMA pigmentosum, *MELANOMA, *OVERALL survival, *SKIN cancer, *INFLAMMATORY mediators, *MONOCYTES

A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients.

Authors: TAUPELET, Florent¹ (AUTHOR), DONNIO, Lise-Marie¹ (AUTHOR), MAGNANI, Charlène¹ (AUTHOR), MARI, Pierre-Olivier¹ (AUTHOR), GIGLIA-MARI, Giuseppina¹ (AUTHOR) ambra.mari@univ-lyon1.fr

Source: PLoS ONE. 7/8/2022, Vol. 17 Issue 7, p1-16. 16p.

Subject Terms: *ORGANELLE formation, *XERODERMA pigmentosum, *RIBOSOMES, *RIBOSOMAL DNA, *RIBOSOMAL RNA, *RNA polymerases, *PROTEINS